Geode Capital Management’s Senti Biosciences SNTI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Buy |
147,314
+117,588
| +396% | +$248K | ﹤0.01% | 3722 |
|
|
2025
Q1 | $99.9K | Buy |
29,726
+2,232
| +8% | +$7.5K | ﹤0.01% | 4031 |
|
|
2024
Q4 | $96.5K | Buy |
27,494
+201
| +0.7% | +$706 | ﹤0.01% | 4106 |
|
|
2024
Q3 | $61.7K | Sell |
27,293
-218,297
| -89% | -$493K | ﹤0.01% | 4221 |
|
|
2024
Q2 | $67.8K | Hold |
245,590
| – | – | ﹤0.01% | 4222 |
|
|
2024
Q1 | $92.6K | Buy |
245,590
+7,184
| +3% | +$2.71K | ﹤0.01% | 4183 |
|
|
2023
Q4 | $157K | Hold |
238,406
| – | – | ﹤0.01% | 4022 |
|
|
2023
Q3 | $101K | Buy |
238,406
+38,219
| +19% | +$16.2K | ﹤0.01% | 4246 |
|
|
2023
Q2 | $125K | Hold |
200,187
| – | – | ﹤0.01% | 4248 |
|
|
2023
Q1 | $236K | Hold |
200,187
| – | – | ﹤0.01% | 3960 |
|
|
2022
Q4 | $282K | Buy |
200,187
+32,912
| +20% | +$46.4K | ﹤0.01% | 3923 |
|
|
2022
Q3 | $362K | Buy |
167,275
+139,152
| +495% | +$301K | ﹤0.01% | 3900 |
|
|
2022
Q2 | $55K | Hold |
28,123
| – | – | ﹤0.01% | 4754 |
|
|
2022
Q1 | $277K | Sell |
28,123
-9,544
| -25% | -$94K | ﹤0.01% | 4217 |
|
|
2021
Q4 | $371K | Buy |
37,667
+3,510
| +10% | +$34.6K | ﹤0.01% | 4192 |
|
|
2021
Q3 | $339K | Hold |
34,157
| – | – | ﹤0.01% | 4206 |
|
|
2021
Q2 | $339K | Buy |
+34,157
| New | +$339K | ﹤0.01% | 4109 |
|